Cytokinetics Inc. buy Wells Fargo & Company
Start price
10.04.26
/
50%
€55.40
Target price
10.04.27
€81.26
Performance (%)
20.72%
Price
31.07.26
€66.88
Summary
This prediction is currently active. The prediction currently has a performance of 20.72%. This prediction currently runs until 10.04.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -5.803% | -5.803% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat